News and Stories About Precision Promise

How Jonathan Lachs is honoring his wife on the one-year anniversary of her passing.

The Precision Promise Supportive Care Committee published a paper on pain management.

In addition to supporting patients and families, PanCAN is advancing research.

PanCAN takes center stage as president and CEO discusses clinical trials and more.

Every day in 2021, 166 Americans will learn that they have pancreatic cancer. That’s 60,430 people who are predicted to […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today’s article describes the complex and changing landscape of clinical […]
READ MORE

Editor’s note: Today’s article looks back at scientific and clinical advances made in 2020 and kicks off our Year in […]
READ MORE

Get a recap of our World Pancreatic Cancer Day webinar featuring an expert panel discussing the latest in clinical research […]

Adaptive Clinical Trial Design Provides A More Cost Effective, Efficient, and Patient-Centric Approach to Clinical Development Los Angeles, Calif. – […]
READ MORE

We recently announced that our groundbreaking new approach to pancreatic cancer clinical trials – PanCAN’s Precision PromiseSM – is open […]
READ MORE

Adaptive Clinical Trial Design Is More Cost Effective, Patient-Centric and Allows for Faster Learning Than Standard Trials Los Angeles, Calif. […]
READ MORE

“The standard clinical trial system is not working fast enough for pancreatic cancer patients.” — Julie Fleshman, JD, MBA, PanCAN […]
READ MORE

The Pancreatic Cancer Action Network’s (PanCAN) Annual Scientific Summit may have looked different this year, but some things stayed the […]
READ MORE

“Accelerating Personalized Care” was the theme for the 2020 Gastrointestinal (GI) Cancers Symposium, which took place Jan. 23-25 in San […]
READ MORE

Editor’s note: This article kicks off our 2019 Year in Review series – highlighting the research advancements that you – […]
READ MORE

Clinical trials are necessary to determine whether a drug or treatment combination is safe, effective and an improvement over the […]
READ MORE

Editor’s note: Pancreatic Cancer Action Network (PanCAN) President and CEO Julie Fleshman attended the Harvard Business School (HBS) Kraft Precision […]
READ MORE

The 2nd International Congress on Clinical Trials in Oncology and Hemato-Oncology (ICTO2018) took place earlier this week in Berlin. The […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) is excited to launch Precision PromiseSM in 2019. Precision Promise is the first adaptive […]
READ MORE

Entrepreneur Skip Viragh was a collaborator. An innovator. A proactive problem-solver. A masterful leader. And he deeply valued these qualities […]
READ MORE

“Let’s face it: The pancreas is a behind-the-scenes organ most of us don’t know – or think – much about. […]
READ MORE

Congratulations to Pancreatic Cancer Action Network (PanCAN) partner Tempus, a technology company building the world’s largest library of molecular and […]
READ MORE

Yesterday, Medscape published a feature story detailing the science behind pancreatic cancer. The article recounts the devastating statistics of the […]
READ MORE

Meet Vincent Picozzi, Jr., MD, director of the pancreaticobiliary program at the Floyd & Delores Jones Cancer Institute at Virginia […]
READ MORE

Last month we welcomed Victoria Manax Rutson, MD, to our team as our first Chief Medical Officer! The need for […]
READ MORE

Earlier this week we announced Precision Promise, the first large-scale precision medicine trial that will put the patient at the […]
READ MORE

Today is a milestone for our organization and the pancreatic cancer community. We have made a promise to transform outcomes […]
READ MORE